Literature DB >> 11011020

Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator.

J Prudlo1, J Koenig, J Gräser, E Burckhardt, P Mestres, M Menger, K Roemer.   

Abstract

Mutant Cu/Zn superoxide dismutase (SOD1) associated with familial amyotrophic lateral sclerosis (FALS) causes selective motor neuron loss through unknown mechanisms of cell damage. Damaged neurons frequently undergo apoptosis mediated by the p53 cell survival regulator. We therefore studied whether motor neuron disease (MND) in mice expressing the human SOD1 mutant G93A is dependent on p53 by crossing G93A mice with p53-knockout mice. Since p53-/- mice's life expectance is usually shorter (160+/-49 days, n=11) than the time at which the G93A mice die from MND (212+/-50 days, n=7), only a few of the G93A/p53-/- double transgenics were expected to live to experience MND. Nevertheless, four of the 22 G93A/p53-/- mice succumbed to MND after 160+/-28 days, as expected under these conditions of competing death risks if the absence of p53 fails to protect from MND. Thus, MND in mice expressing G93A does not require p53. This conclusion is supported by histology: pre-symptomatic G93A mice display disease-associated vacuoles within the dendrites of motor neurons regardless of p53 status.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11011020     DOI: 10.1016/s0006-8993(00)02745-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  p53-dependent cell death signaling in neurons.

Authors:  Richard S Morrison; Yoshito Kinoshita; Mark D Johnson; Weiqun Guo; Gwenn A Garden
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 2.  Programmed cell death in amyotrophic lateral sclerosis.

Authors:  Christelle Guégan; Serge Przedborski
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 3.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

4.  p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS.

Authors:  Srikanth Ranganathan; Robert Bowser
Journal:  Open Pathol J       Date:  2010-01-01

Review 5.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice.

Authors:  Dairín Kieran; Ina Woods; Andreas Villunger; Andreas Strasser; Jochen H M Prehn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

Review 7.  Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.

Authors:  Barry W Festoff; Zhiming Suo; Bruce A Citron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Transcriptional activator TAp63 is upregulated in muscular atrophy during ALS and induces the pro-atrophic ubiquitin ligase Trim63.

Authors:  Yannick von Grabowiecki; Paula Abreu; Orphee Blanchard; Lavinia Palamiuc; Samir Benosman; Sophie Mériaux; Véronique Devignot; Isabelle Gross; Georg Mellitzer; José L Gonzalez de Aguilar; Christian Gaiddon
Journal:  Elife       Date:  2016-02-26       Impact factor: 8.140

Review 9.  State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model.

Authors:  Renaid B Kim; Cameron W Irvin; Keval R Tilva; Cassie S Mitchell
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-05-22       Impact factor: 4.092

10.  TDP-43 induces p53-mediated cell death of cortical progenitors and immature neurons.

Authors:  Miriam A Vogt; Zahra Ehsaei; Philip Knuckles; Adrian Higginbottom; Michaela S Helmbrecht; Tilo Kunath; Kevin Eggan; Luis A Williams; Pamela J Shaw; Wolfgang Wurst; Thomas Floss; Andrea B Huber; Verdon Taylor
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.